Figure 2.
Influence of treatment of Treg-cell frequency. Different approaches affecting Treg-cell frequencies and function have been proposed in recent years and tested either in murine models or first clinical trials. Targeting of Treg cells in human tumors, however, does not always result in reduced Treg-cell numbers but may also, under given circumstances, be linked to the induction of autoimmunity or the expansion or development of Treg cells.